Phenergan, Phenadoz promethazine dosing, indications. Generic Name: Promethazine hydrocoride Product Name: Phenergan Phenergan is an antihistamine used in the treatment of allergies; to stop nausea and vomiting; and for sedation and premedication.
Sickness, nausea, vomiting-specific dosing for Phenergan, Phenadoz promethazine. Brand and Other NamesPhenergan, Phenadoz. AdultPediatric.
Promethazine Recommendations for Safe Use in Children Single 25-mg doses at bedtime or 6.25 to 12.5 mg taken three times daily will usually suffice.
Promethazine Recommendations for Safe Use in Children. The recommended pediatric dose of promethazine to provide an antihistamine. Phenergan® prescribing.
Phenergan Injection Dosage Guide - Topical cortisone may but often only Rx strength cortisone is needed. The older antihistamine works by causing sedation . Read more If she is otherwise well,it should be alrht.
PHENERGAN Injection in doses of 50 mg will provide sedation and relieve. In pediatric patients 2 years of age and older, the dosage should not exceed half.
Phenergan ® - product information - Sanofi Sedation Confusion Disorientation Blurred vision Hallucinations Dystonias Catatonic states Euphoria Excitation Extrapyramidal symptoms Tachycardia Bradycardia Leukopenia (rare) Agranulocytosis (rare) Obstructive jaundice Photosensitivity Dry mouth Angioneurotic edema Tardive dyskinesia Urticaria Xerostomia Impotence Urinary retention IV administration can cause severe tissue injury, including burning, gangrene, or thrombopebitis, necessitating fasciotomy, skin graft, or amputation Severe tissue injury can occur from perivascular extravasation, unintentional intra-arterial injection, and intraneuronal or perineuronal infiltration Deep IM injection is preferred method of administration Intra-arterial and SC administration are contraindicated 25 mg/m L product may be administered by deep IM injection or IV infusion (at rate not to exceed 25 mg/min through flowing IV tubing) Monitor for sns and symptoms of potential tissue injury including burning or pain at site of injection, pebitis, swelling, and blistering Discontinue IV infusion immediately if patient complains of pain during injection Respiratory fatalities reported with use in children Use caution in asthma, hepatic impairment, peptic ulcer disease, respiratory impairment, bone marrow suppression, anaphylaxis in susceptible individuals May impair ability to drive or perform hazardous tasks May impair core body temperature regulation; caution when taking medications with anticholinergic effects, heat exposure, or strenuous exercise Depresses hypothalamic thermoregulatory mechanism; exposure to extreme temperatures may cause hypo- or hyperthermia May alter cardiac conduction (life-threatening arrhythmias reported) Antiemetic effect may obscure toxicity of chemotherapeutic drugs Monitor closely in patients with cardiovascular disease, hepatic impairment, Reye syndrome, or history of sleep apnea Has anticholinergic effects; use with caution in patients with decreased gastrointestinal motility or obstructions (partial or comlete), urinary retention, urinary obstructions, xerostomia, BPH, or visual problems May cause extrapyramidal symptoms including pseudoparkinsonism, acute dystonic reactions, tardive dyskinesia, and akathisia Neuroleptic malnant syndrome reported with use; monitor for fever, muscle ridity and/or autonomic instability, or mental status changes May cause orthostatic hypotension; use caution in patients at risk of experiencing hypotensive episodes (cardiovascular disease, cerebrovascular disease, hypovolemia or taking medications that may predispose to bradycardia or hypotension) May cause photosensitivity Pyloroduodenal obstruction, stenosing peptic ulcer disease, bladder neck obstruction Anticholinergic effects of promethazine may exacerbate condition in patients with narrow-angle glaucoma or myasthenia gravis Bioavailability: 25% (PO/PR) Onset (antihistaminic effect): 3-5 min (IV); 20 min (IM/PO/PR) Peak serum time: 6.7-8.6 hr (suppositories); 4.4 hr (syrup) Duration: PO (motion sickness), 4-6 hr; IV (nausea and vomiting), 4-6 hr; up to 12 hr Solution: Compatible with most common solvents Additive: Amikacin, ascorbic acid injection, coroquine, hydromorphone, netilmicin, vitamins B and C Syringe (partial list): Atropine, diphenhydramine, fentanyl, meperidine, morphine sulfate(? ) The above information is provided for general informational and educational purposes only.
Phenergan Elixir contains promethazine hydrocoride 5 mg / 5 mL. Phenergan. be reversible. When promethazine has been given in hh doses during late pregnancy, promethazine has. Paediatric Use. Children may.
Phenergan Dm Dosage - Azimuth Productions Applies to the following strength(s): 12.5 mg ; 6.25 mg/5 m L ; 25 mg ; 25 mg/m L ; 50 mg ; 25 mg/5 m L ; 50 mg/m L ; 25 mg/25 m L-Na Cl 0.9% The information at is not a substitute for medical advice. Parenteral: 25 mg IV or IM once, followed by close observation for response. Alternatively, a single 25 mg dose given at bedtime or 6.25 mg to 12.5 mg three times daily.
Phenergan Dm Dosage 1 phenergan iv push. Phenergan Pediatric Dose Mg Kg Subject Can dogs take phenergan for nausea, phenergan cough syrup dosage.
DOSAGES PRINCIPES ACTIFS PEDIATRIQUES Irritation and damage can result from perivascular extravasation, unintentional intra-arterial injection, and intraneuronal or perineuronal infiltration (see WARNINGS - Severe Tissue Injury, Including Gangrene).
Promethazine Phenergan 0,5 à 1mg / kg / 24h en 1 ou 2 prise Propranolol Avlocardyl 0,5 à 4mg / kg / 24h en 3 ou 4 prises Pyrazinamide Pirilene 20mg / kg / 24h.
Phenergan dose pediatric:
Rating: 95 / 100
Overall: 92 Rates